CLINICAL_TRIALS
trial_result
· 2023-06-22
Clinical Trial Update: Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia [Phase 2]
Summary
Phase 2 trial evaluating alemtuzumab plus peripheral stem cell transplantation in patients with leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eastern Cooperative Oncology Group | Conditions: Leukemia | Phase 2 | Status: COMPLETED